In addition, we will also test these compounds in different TTR amyloidogenic variants and other amyloid systems, such as the amyloid-beta peptide and lysozyme, which are implicated in Alzheimer’s disease and lysozyme amyloidosis [1], respectively. Here, TTR is linked to amyloidosis.